Study Suggests AMR Prevalence In WHO Gram-Negative Priority Pathogens May Be “Substantial” In Countries Lacking Current Data

According to Healio (5/1, Stulpin), “New estimates presented at ESCMID Global Congress show that antimicrobial resistance [AMR] prevalence in WHO gram-negative priority pathogens may be ‘substantial’ in countries lacking current data.” Study researchers developed a machine learning-driven “stacked ensemble modeling approach” to “estimate AMR prevalence in countries lacking data” and found “that resistance to third-generation cephalosporins in E. coli and resistance to carbapenems in A. baumannii are both on the rise, with a notably sharp increase observed in Sub-Saharan Africa and South Asia between 2004 and 2021.”